On January 9, 2020 Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, reported that the company will participate in the upcoming 38th Annual J.P. Morgan Healthcare Conference (Press release, Ascendis Pharma, JAN 9, 2020, View Source [SID1234552917]). Company executives will provide a business overview and update on the company’s pipeline programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details

Event 38th Annual J.P. Morgan Healthcare Conference
Location San Francisco
Date Monday, January 13, 2020
Time Presentation: 8:00 a.m. Pacific Time (PT)
Question & Answer Session: 8:30 a.m. PT
Live webcasts of both the presentation and Q&A session will be available in the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the event for 30 days.